3 results match your criteria: "Department of Ophthalmology University of Virginia[Affiliation]"
Case Rep Ophthalmol Med
July 2024
Department of Ophthalmology University of Virginia, Charlottesville, Virginia, USA.
Visible-light optical coherence tomography (vis-OCT) is a novel noninvasive retinal imaging system that offers improved resolution compared to conventional near-infrared (NIR) OCT systems. Here, we utilized vis-OCT to produce fibergrams (vis-OCTF) for the first time in human patients, enabling visualization and precise quantification of hyperreflective dots in the central fovea in two patients. We also directly compare the imaging qualities of conventional vis-OCT and NIR-OCT.
View Article and Find Full Text PDFCase Rep Oncol
January 2024
Department of Ophthalmology, Virginia Commonwealth University Medical Center, Richmond, VA, USA.
Introduction: Ipilimumab and nivolumab are checkpoint inhibitors that are known to cause a multitude of inflammatory ocular adverse events. Here we report a patient with poliosis and symptomatic depigmentation of the choroid and retinal pigment epithelium (RPE) associated with checkpoint inhibitor therapy for cutaneous melanoma.
Case Presentation: The patient presented with floaters in both eyes and concerns for intraocular metastases of metastatic cutaneous melanoma after 1 month of therapy with ipilimumab and nivolumab.
Ophthalmic Plast Reconstr Surg
November 2003
Department of Ophthalmology University of Virginia, Charlottesville, Virginia, USA.
Purpose: To investigate the mechanisms producing ptosis in anophthalmic patients by comparing potential risk factors among patients with ptosis with a control group. Specific techniques for achieving optimal aesthetic results in the surgical correction of anophthalmic ptosis are recommended.
Methods: Data from 94 anophthalmic patients with ptosis and 44 control patients without ptosis were retrospectively collected and analyzed.